Clearmind Medicine (CMND) Competitors $0.86 -0.03 (-3.83%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CMND vs. PMN, GOVX, PRPH, LPTX, VYNE, ALVR, FLGC, MEIP, BLRX, and EDSAShould you be buying Clearmind Medicine stock or one of its competitors? The main competitors of Clearmind Medicine include ProMIS Neurosciences (PMN), GeoVax Labs (GOVX), ProPhase Labs (PRPH), Leap Therapeutics (LPTX), VYNE Therapeutics (VYNE), AlloVir (ALVR), Flora Growth (FLGC), MEI Pharma (MEIP), BioLineRx (BLRX), and Edesa Biotech (EDSA). These companies are all part of the "pharmaceutical products" industry. Clearmind Medicine vs. Its Competitors ProMIS Neurosciences GeoVax Labs ProPhase Labs Leap Therapeutics VYNE Therapeutics AlloVir Flora Growth MEI Pharma BioLineRx Edesa Biotech ProMIS Neurosciences (NASDAQ:PMN) and Clearmind Medicine (NASDAQ:CMND) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, media sentiment, valuation, profitability, analyst recommendations, community ranking, institutional ownership, risk and dividends. Is PMN or CMND more profitable? Clearmind Medicine's return on equity of -129.21% beat ProMIS Neurosciences' return on equity.Company Net Margins Return on Equity Return on Assets ProMIS NeurosciencesN/A -636.20% -130.32% Clearmind Medicine N/A -129.21%-61.15% Do analysts recommend PMN or CMND? ProMIS Neurosciences currently has a consensus price target of $4.50, indicating a potential upside of 765.38%. Given ProMIS Neurosciences' stronger consensus rating and higher possible upside, research analysts plainly believe ProMIS Neurosciences is more favorable than Clearmind Medicine.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ProMIS Neurosciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Clearmind Medicine 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk and volatility, PMN or CMND? ProMIS Neurosciences has a beta of -0.08, suggesting that its share price is 108% less volatile than the S&P 500. Comparatively, Clearmind Medicine has a beta of 0.91, suggesting that its share price is 9% less volatile than the S&P 500. Does the media prefer PMN or CMND? In the previous week, Clearmind Medicine had 3 more articles in the media than ProMIS Neurosciences. MarketBeat recorded 4 mentions for Clearmind Medicine and 1 mentions for ProMIS Neurosciences. ProMIS Neurosciences' average media sentiment score of 1.89 beat Clearmind Medicine's score of 1.21 indicating that ProMIS Neurosciences is being referred to more favorably in the media. Company Overall Sentiment ProMIS Neurosciences Very Positive Clearmind Medicine Positive Do insiders & institutionals have more ownership in PMN or CMND? 50.1% of ProMIS Neurosciences shares are held by institutional investors. Comparatively, 96.1% of Clearmind Medicine shares are held by institutional investors. 6.1% of ProMIS Neurosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the MarketBeat Community prefer PMN or CMND? ProMIS Neurosciences received 5 more outperform votes than Clearmind Medicine when rated by MarketBeat users. CompanyUnderperformOutperformProMIS NeurosciencesOutperform Votes5100.00% Underperform VotesNo VotesClearmind MedicineN/AN/A Which has higher earnings & valuation, PMN or CMND? ProMIS Neurosciences is trading at a lower price-to-earnings ratio than Clearmind Medicine, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProMIS NeurosciencesN/AN/A-$13.21M-$0.05-10.40Clearmind MedicineN/AN/A-$5.26M-$1.22-0.70 SummaryProMIS Neurosciences and Clearmind Medicine tied by winning 7 of the 14 factors compared between the two stocks. Get Clearmind Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for CMND and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CMND and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CMND vs. The Competition Export to ExcelMetricClearmind MedicinePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.65M$6.92B$5.61B$8.62BDividend YieldN/A2.55%5.28%4.17%P/E Ratio-0.468.6727.1419.96Price / SalesN/A262.53411.83157.63Price / CashN/A65.8538.2534.64Price / Book1.176.597.064.69Net Income-$5.26M$143.75M$3.23B$248.14M7 Day Performance-8.89%3.72%2.67%2.39%1 Month Performance-13.33%11.01%8.82%6.05%1 Year Performance-21.44%3.87%31.44%13.60% Clearmind Medicine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CMNDClearmind Medicine1.2794 of 5 stars$0.86-3.8%N/A-12.7%$3.65MN/A-0.46N/ANews CoverageEarnings ReportShort Interest ↓Gap DownPMNProMIS Neurosciences2.3819 of 5 stars$0.49-2.0%$4.50+818.4%-68.7%$16.02MN/A-4.905Positive NewsGap DownGOVXGeoVax Labs3.4559 of 5 stars$1.05+1.0%$11.10+957.1%-26.5%$15.95M$5.59M-0.2910News CoveragePRPHProPhase Labs1.2786 of 5 stars$0.38+1.9%N/A-92.2%$15.82M$5.85M-0.30130Short Interest ↑LPTXLeap Therapeutics2.655 of 5 stars$0.37+3.3%$4.92+1,227.0%-80.6%$15.35MN/A-0.1940Positive NewsGap DownVYNEVYNE Therapeutics2.5157 of 5 stars$1.00+7.8%$6.25+525.0%-59.7%$15.21M$605K-1.1630Short Interest ↑High Trading VolumeALVRAlloVirN/A$3.00+3.4%N/A-83.2%$15.13MN/A-0.15110News CoverageFLGCFlora Growth2.7448 of 5 stars$0.66+3.2%$4.00+505.6%-29.8%$14.91M$53.26M-0.67280News CoveragePositive NewsMEIPMEI Pharma1.6963 of 5 stars$2.15-3.2%N/A-17.1%$14.32M$65.30M-0.38100News CoveragePositive NewsShort Interest ↑BLRXBioLineRx3.4913 of 5 stars$4.22+2.9%$26.00+516.1%-80.0%$14.05M$22.34M-0.4840Gap DownEDSAEdesa Biotech3.3679 of 5 stars$1.99flat$21.00+955.3%-58.2%$13.98MN/A-1.0620Positive NewsShort Interest ↓Gap Up Related Companies and Tools Related Companies PMN Competitors GOVX Competitors PRPH Competitors LPTX Competitors VYNE Competitors ALVR Competitors FLGC Competitors MEIP Competitors BLRX Competitors EDSA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CMND) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored50-year legend: Here’s exact day stocks will crashGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearmind Medicine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearmind Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CMND Stock Free CMND Stock Alerts